Investing
Top Day Trader Alert Stocks (CIT, C, GS, JNJ, NVAX, VNDA, VASC)
Published:
Last Updated:
These are this morning’s top day trader alert stocks. We have more detailed price and volume analysis on each stock link over at VSInvestor.com:
CIT Group Inc. (NYSE: CIT) is getting crushed and is back under $1.00 on its news this morning.
Goldman Sachs Group Inc. (NYSE: GS) is down almost 2% on the Meredith Whitney downgrade.
Citigroup, Inc. (NYSE: C) is up marginally despite an analyst “BUY” recommendation.
Johnson & Johnson (NYSE: JNJ) is down 2.5% at $60.95 despite beating earnings because revenues were light and ‘raised guidance’ looks effectively in-line.
Novavax, Inc. (NASDAQ: NVAX) is rising over 7% on a small NIH grant.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of this morning’s top gainers on a a Novartis pact.
Vascular Solutions, Inc. (NASDAQ: VASC) is another top percentage gainer on FDA marketing approval for its next-generation Guardian II Hemostasis valve.
You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.
JON C. OGG
OCTOBER 13, 2009
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
